An FDA advisory panel recently voted to green-light some popular peptides. The decision brought enormous attention to the market for these products — and concerns about the unregulated supply.
The popular and experimental drugs called peptides received unprecedented attention last month during a marathon hearing held by a panel that advises the Food and Drug Administration.
Catherine Falls Commercial/Getty Images
hide caption
toggle caption
Catherine Falls Commercial/Getty Images
Peptides: The FDA opens a ‘Pandora’s box’
FDA Panel Backs Wider Access To Six Peptide Therapies, Citing Grey Market Concerns
On Peptides, FDA Staff Scientists At Odds With Advisory Panel
FDA advisers support easing restrictions on six peptides. Here’s what those drugs are and what happens next | CNN
The FDA stacked a panel with peptide sellers. Guess what it just greenlit
